Skip to content

Clinical trials

Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20081
20101
20111
20124
20131
20142
20151
20165
20179
20182
20192
20205
20217
20224
20234
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status14
Recruiting9
Terminated9
Active, not recruiting8
Not yet recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Blueprint Medicines Corporation4
Eli Lilly and Company3
Fundación GECP3
Hoffmann-La Roche3
Jiangsu HengRui Medicine Co., Ltd.2
Revolution Medicines, Inc.2
University Hospital, Angers2
VA Office of Research and Development2
Weill Medical College of Cornell University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic65
Lung Neoplasms44
Carcinoma, Non-Small-Cell Lung40
Lung Diseases35
Neoplasms35
Thoracic Neoplasms35
Respiratory Tract Neoplasms32
Bronchial Neoplasms30
Respiratory Tract Diseases30
Neoplasms by Site29

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.